Zhuxing Chen

701 total citations · 1 hit paper
18 papers, 363 citations indexed

About

Zhuxing Chen is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Zhuxing Chen has authored 18 papers receiving a total of 363 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Zhuxing Chen's work include Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Diagnosis and Treatment (7 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Zhuxing Chen is often cited by papers focused on Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Diagnosis and Treatment (7 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Zhuxing Chen collaborates with scholars based in China, United States and Singapore. Zhuxing Chen's co-authors include Jianxing He, Wenhua Liang, Caichen Li, Jianfu Li, Ran Zhong, Bo Cheng, Shan Xiong, Zhanhong Xie, Xiuyu Cai and Ziwen Yu and has published in prestigious journals such as European Radiology, Critical Reviews in Oncology/Hematology and ACS Omega.

In The Last Decade

Zhuxing Chen

14 papers receiving 360 citations

Hit Papers

The association between CD8+ tumor-infiltrating lymphocyt... 2021 2026 2022 2024 2021 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhuxing Chen China 8 231 145 108 54 51 18 363
Jahan Aghalar United States 5 269 1.2× 133 0.9× 98 0.9× 47 0.9× 25 0.5× 9 355
Sofia Westbom-Fremer Sweden 7 187 0.8× 99 0.7× 68 0.6× 56 1.0× 39 0.8× 12 299
Miao Huang China 9 184 0.8× 159 1.1× 50 0.5× 61 1.1× 33 0.6× 17 298
Brad Wasserman United States 7 347 1.5× 144 1.0× 104 1.0× 29 0.5× 29 0.6× 10 418
Zeming Mo China 7 164 0.7× 113 0.8× 67 0.6× 78 1.4× 46 0.9× 11 369
Jian Zhong China 9 114 0.5× 104 0.7× 52 0.5× 63 1.2× 75 1.5× 23 256
Francesca Sparano Italy 9 219 0.9× 103 0.7× 78 0.7× 113 2.1× 21 0.4× 19 369
Virginia Palomar Coloma France 4 421 1.8× 190 1.3× 118 1.1× 42 0.8× 30 0.6× 5 481
Elena García-Martínez Spain 9 350 1.5× 75 0.5× 223 2.1× 59 1.1× 39 0.8× 19 473

Countries citing papers authored by Zhuxing Chen

Since Specialization
Citations

This map shows the geographic impact of Zhuxing Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhuxing Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhuxing Chen more than expected).

Fields of papers citing papers by Zhuxing Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhuxing Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhuxing Chen. The network helps show where Zhuxing Chen may publish in the future.

Co-authorship network of co-authors of Zhuxing Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Zhuxing Chen. A scholar is included among the top collaborators of Zhuxing Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhuxing Chen. Zhuxing Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Yang, Shengli, Peixian Li, Xiaowen Zhang, et al.. (2025). High-Throughput Peptide Array Clinical Validation for Lung Adenocarcinoma Detection. ACS Omega. 10(21). 21857–21866.
2.
Liang, Wenhua, Xin Liu, Zhuxing Chen, et al.. (2024). General anesthesia induces acute cell-free DNA methylation changes in peripheral blood. Journal of Thoracic Disease. 16(11). 7592–7606.
3.
Zhu, Feng, Ran Zhong, Feng Li, et al.. (2023). Development and validation of a deep transfer learning-based multivariable survival model to predict overall survival in lung cancer. Translational Lung Cancer Research. 12(3). 471–482. 7 indexed citations
4.
Ou, Limin, Xiuyu Cai, Liyan Huang, et al.. (2023). Laboratory blood test profiling reveals distinct biochemical and hemocyte features of KRAS mutated non-small cell lung cancer. Journal of Thoracic Disease. 15(2). 365–375.
5.
Xiong, Shan, Hengrui Liang, Peng Liang, et al.. (2023). Predilection site and risk factor of second primary cancer: A pan-cancer analysis based on the SEER database. Chinese Medical Journal. 136(12). 1500–1502.
6.
Chen, Zhuxing, Liping Liu, Feng Zhu, et al.. (2022). Dynamic monitoring serum tumor markers to predict molecular features of EGFR‐mutated lung cancer during targeted therapy. Cancer Medicine. 11(16). 3115–3125. 5 indexed citations
7.
Deng, Hongsheng, Hengrui Liang, Jiawei Chen, et al.. (2022). Preoperative immunochemotherapy for locally advanced non-small cell lung cancer: an analysis of the clinical outcomes, optimal number of cycles, and peripheral immune markers. Translational Lung Cancer Research. 11(12). 2364–2381. 16 indexed citations
8.
Cheng, Bo, Hongsheng Deng, Yi Zhao, et al.. (2022). Predicting EGFR mutation status in lung adenocarcinoma presenting as ground-glass opacity: utilizing radiomics model in clinical translation. European Radiology. 32(9). 5869–5879. 26 indexed citations
9.
Wang, Runchen, Qixia Wang, Shunjun Jiang, et al.. (2022). Spontaneous Ventilation Video-Assisted Thoracoscopic Surgery for Non-small-cell Lung Cancer Patients With Poor Lung Function: Short- and Long-Term Outcomes. Frontiers in Surgery. 9. 800082–800082. 5 indexed citations
10.
Cheng, Bo, Hongsheng Deng, Yi Zhao, et al.. (2021). Management for Residual Ground-Glass Opacity Lesions After Resection of Main Tumor in Multifocal Lung Cancer: A Case Report and Literature Review. Cancer Management and Research. Volume 13. 977–985. 10 indexed citations
11.
Chen, Zhuxing, Feng Zhu, Caichen Li, et al.. (2021). Non-small cell lung cancer with MET exon 14 skipping alteration responding to immunotherapy: a case report. Annals of Translational Medicine. 9(5). 424–424. 3 indexed citations
12.
Liang, Hengrui, Runchen Wang, Ran Zhong, et al.. (2021). Perioperative and long-term outcomes of spontaneous ventilation video-assisted thoracoscopic surgery for non-small cell lung cancer. Translational Lung Cancer Research. 10(10). 3875–3887. 13 indexed citations
13.
Chen, Zhuxing, Junguo Dong, Yongfu Ma, et al.. (2021). Artificial intelligence assisted display in thoracic surgery: development and possibilities. Journal of Thoracic Disease. 13(12). 6994–7005. 14 indexed citations
14.
Jiang, Yu, Caichen Li, Ran Zhong, et al.. (2021). Relationship between lung function and lung cancer risk: a pooled analysis of cohorts plus Mendelian randomization study. Journal of Cancer Research and Clinical Oncology. 147(10). 2837–2849. 9 indexed citations
15.
Zhu, Feng, Jianfu Li, Caichen Li, et al.. (2021). Concealed driver in lung adenocarcinoma with single PIK3CA mutation: a case report and single-center genotyping review. Annals of Translational Medicine. 9(3). 271–271. 2 indexed citations
16.
Li, Feng, Caichen Li, Xiuyu Cai, et al.. (2021). The association between CD8+ tumor-infiltrating lymphocytes and the clinical outcome of cancer immunotherapy: A systematic review and meta-analysis. EClinicalMedicine. 41. 101134–101134. 211 indexed citations breakdown →
17.
Zhao, Yi, Bo Cheng, Zisheng Chen, et al.. (2021). Toxicity profile of epidermal growth factor receptor tyrosine kinase inhibitors for patients with lung cancer: A systematic review and network meta-analysis. Critical Reviews in Oncology/Hematology. 160. 103305–103305. 41 indexed citations
18.
Li, Shuben, et al.. (2021). Non-intubated thoracic surgery: an Asian perspective. 6. 24–24. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026